ZW19784A1 - Derivatives of 2,2'-iminobisethanol - Google Patents

Derivatives of 2,2'-iminobisethanol

Info

Publication number
ZW19784A1
ZW19784A1 ZW197/84A ZW19784A ZW19784A1 ZW 19784 A1 ZW19784 A1 ZW 19784A1 ZW 197/84 A ZW197/84 A ZW 197/84A ZW 19784 A ZW19784 A ZW 19784A ZW 19784 A1 ZW19784 A1 ZW 19784A1
Authority
ZW
Zimbabwe
Prior art keywords
iminobisethanol
derivatives
Prior art date
Application number
ZW197/84A
Other languages
English (en)
Inventor
Van Lommen Guy
De Bruyn Marcel
Schroven Marc
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZW19784A1 publication Critical patent/ZW19784A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZW197/84A 1983-12-05 1984-12-04 Derivatives of 2,2'-iminobisethanol ZW19784A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55808183A 1983-12-05 1983-12-05

Publications (1)

Publication Number Publication Date
ZW19784A1 true ZW19784A1 (en) 1986-07-02

Family

ID=24228139

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW197/84A ZW19784A1 (en) 1983-12-05 1984-12-04 Derivatives of 2,2'-iminobisethanol

Country Status (32)

Country Link
EP (1) EP0145067B1 (cs)
JP (1) JPS60132977A (cs)
KR (1) KR870000923B1 (cs)
AR (1) AR241414A1 (cs)
AT (1) ATE40361T1 (cs)
AU (1) AU573658B2 (cs)
BG (1) BG43866A3 (cs)
CA (1) CA1337429C (cs)
CS (1) CS250242B2 (cs)
CY (1) CY1609A (cs)
DD (1) DD235453A5 (cs)
DE (1) DE3476388D1 (cs)
DK (2) DK165112C (cs)
DZ (1) DZ712A1 (cs)
ES (1) ES538256A0 (cs)
FI (1) FI82460C (cs)
GR (1) GR81098B (cs)
HK (1) HK52791A (cs)
HU (1) HU202219B (cs)
IE (1) IE57831B1 (cs)
IL (1) IL73706A (cs)
MA (1) MA20292A1 (cs)
NO (2) NO169839C (cs)
NZ (1) NZ210388A (cs)
PH (1) PH22432A (cs)
PL (1) PL146342B1 (cs)
PT (1) PT79609B (cs)
RO (1) RO91184B (cs)
SG (1) SG47091G (cs)
SU (1) SU1428199A3 (cs)
ZA (1) ZA849445B (cs)
ZW (1) ZW19784A1 (cs)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02103116U (cs) * 1989-02-01 1990-08-16
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd 6―フルオロクロモン―2―カルボン酸及びその製造法
IE68675B1 (en) * 1990-11-01 1996-07-10 Takeda Chemical Industries Ltd Aminocoumaran derivatives their production and use
SK282402B6 (sk) * 1993-08-19 2002-01-07 Janssen Pharmaceutica N. V. Deriváty dihydrobenzopyránu, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutický prostriedok na ich báze
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
PT707007E (pt) * 1994-10-14 2002-06-28 Merck Patent Gmbh Derivados amino(tio)eter como agentes activos no snc
WO1997046548A1 (en) * 1996-06-07 1997-12-11 The Procter & Gamble Company Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
SK9362000A3 (en) * 1997-12-19 2001-09-11 Bayer Ag Carboxyl substituted chroman derivatives useful as beta-3-adrenoreceptor agonists
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6362371B1 (en) 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
DE60233140D1 (de) 2001-05-02 2009-09-10 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
WO2003009835A2 (en) 2001-07-26 2003-02-06 Merck Patent Gmbh Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en) 2001-11-13 2003-11-25 Theravance, Inc. Aryl aniline β2 adrenergic receptor agonists
BRPI0513672A (pt) 2004-07-30 2008-05-13 Torrent Pharmaceuticals Limita processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)' [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
WO2006016376A1 (en) * 2004-08-11 2006-02-16 Hetero Drugs Limited A novel process for preparation of nebivolol intermediates
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α,α’-[亚氨基二(亚甲基)]-双-(6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲醇)甲烷磺酸盐的合成方法
EP1848424B1 (en) 2005-01-31 2017-04-05 Mylan Laboratories, Inc Pharmaceutical composition comprising hydroxylated nebivolol
NZ560385A (en) * 2005-01-31 2010-10-29 Mylan Lab Inc Glucuronidated nebivolol metabolites
EP1850842A1 (de) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
RU2392277C2 (ru) * 2005-12-28 2010-06-20 Асино Фарма Аг Способ получения рацемического небиволола
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
WO2007083318A1 (en) 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
CN103087028B (zh) 2006-11-27 2014-12-24 Zach系统股份公司 制备奈必洛尔的方法
WO2008089549A1 (en) 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1392067B1 (it) * 2008-10-31 2012-02-09 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
ES2700973T3 (es) 2014-02-14 2019-02-20 Corden Pharma Int Gmbh Proceso sin base para la preparación de compuestos intermedios de cetona que se pueden usar para fabricar nebivolol
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
US10526304B2 (en) 2015-05-19 2020-01-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Nebivolol synthesis method and intermediate compound thereof
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054655A (cs) * 1964-01-24
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
KR870000923B1 (ko) 1987-05-07
NO169839B (no) 1992-05-04
HU202219B (en) 1991-02-28
FI844777A0 (fi) 1984-12-04
EP0145067A2 (en) 1985-06-19
NO2004007I2 (no) 2005-05-09
DE3476388D1 (en) 1989-03-02
DK577084A (da) 1985-06-06
MA20292A1 (fr) 1985-07-01
DK165112B (da) 1992-10-12
ES8603870A1 (es) 1986-01-01
SG47091G (en) 1991-07-26
ZA849445B (en) 1986-07-30
CY1609A (en) 1992-04-03
EP0145067B1 (en) 1989-01-25
NO169839C (no) 1992-08-12
DK165321C (da) 1993-03-29
ES538256A0 (es) 1986-01-01
DZ712A1 (fr) 2004-09-13
NO2004007I1 (no) 2004-12-20
ATE40361T1 (de) 1989-02-15
AU3632684A (en) 1985-06-13
BG43866A3 (en) 1988-08-15
IL73706A (en) 1988-07-31
SU1428199A3 (ru) 1988-09-30
JPS60132977A (ja) 1985-07-16
FI844777L (fi) 1985-06-06
DD235453A5 (de) 1986-05-07
HK52791A (en) 1991-07-19
DK11892A (da) 1992-01-31
EP0145067A3 (en) 1986-03-26
PT79609B (en) 1986-12-12
JPH0250114B2 (cs) 1990-11-01
IE843103L (en) 1985-06-05
RO91184A (ro) 1987-07-30
NZ210388A (en) 1987-07-31
DK11892D0 (da) 1992-01-31
NO844845L (no) 1985-06-06
PT79609A (en) 1985-01-01
AU573658B2 (en) 1988-06-16
GR81098B (en) 1984-12-17
DK165321B (da) 1992-11-09
KR850004485A (ko) 1985-07-15
IE57831B1 (en) 1993-04-21
CA1337429C (en) 1995-10-24
DK577084D0 (da) 1984-12-04
PL250524A1 (en) 1986-02-25
CS250242B2 (en) 1987-04-16
DK165112C (da) 1993-03-01
PH22432A (en) 1988-09-12
RO91184B (ro) 1987-07-31
AR241414A1 (es) 1992-07-31
HUT37418A (en) 1985-12-28
FI82460C (fi) 1991-03-11
IL73706A0 (en) 1985-03-31
PL146342B1 (en) 1989-01-31
FI82460B (fi) 1990-11-30

Similar Documents

Publication Publication Date Title
DE3476388D1 (en) Derivatives of 2,2'-iminobisethanol
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
GB8716897D0 (en) 1 4-dihydro-4-oxonaphthyridine derivatives
GR82558B (en) Novel derivatives
GB8418744D0 (en) 1,5-benzothiazepine derivatives
EP0145023A3 (en) 3, 3", 4" -tri-o-acylspiramycin i
GB8426657D0 (en) 1 2-dithiolan derivatives
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
GB8414968D0 (en) Dianthraquinone-n n'-dihydrazine
GB8321943D0 (en) Preparation of 2,3-dihydro-benzopyranone derivatives
IL74595A0 (en) 1,2,4-triazacycloalkadiene derivatives
PH20351A (en) Novel acylaminophenal derivatives
GB8312665D0 (en) 4,4'-alkylenedipiperidine derivatives
GB8402836D0 (en) 3-o-acyl-4"-deoxy-desmycosin derivatives
GB8431131D0 (en) 2 6-dioxopiperidine derivatives
GB8507490D0 (en) Preparing 2 2-bishalomethylpenam derivatives
IL70629A0 (en) Preparation of n,n'-diformylhydrazine
GB2163148B (en) Phenyl derivatives of 2,4-dimethyl-2-hexene
GB8523735D0 (en) 1,2-benzoxathiine derivatives
GB2152036B (en) 4,5,6,7-tetrahydrobenzimidazole derivatives
ZM7084A1 (en) Derivatives of 2,2-iminobisethanol
GB2154238B (en) 2 imidomethyl-penem derivatives
IE831682L (en) Derivatives of 2-azabicyclo £2,2,2| octane -3- carboxylic¹acid
GB8430451D0 (en) 2 6-dioxopiperidine derivatives
GB8407793D0 (en) 13 14 19 20-retrade-hydro derivatives